Magnolia Vanegas

Magnolia Vanegas


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2009 in Vaccine
Verified
Journal Article
Closed access
JGJeison García
Jeison García
HCHernando Curtidor
Hernando Curtidor
CPCarlos G. Pinzón
Carlos G. Pinzón
MVMagnolia Vanegas
Magnolia Vanegas
AMArmando Moreno
Armando Moreno
MPManuel Alfonso Patarroyo
Manuel Alfonso Patarroyo

24 June 2010 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
CVCarolina Vizcaíno
Carolina Vizcaíno
DRDaniel Restrepo-Montoya
Daniel Restrepo-Montoya
DRDiana Rodríguez
Diana Rodríguez
LNLuis F. Niño
Luis F. Niño
MOMarisol Ocampo
Marisol Ocampo
MPManuel Alfonso Patarroyo
Manuel Alfonso Patarroyo
The mycobacterial cell envelope has been implicated in the pathogenicity of tuberculosis and therefore has been a prime target for the identification and characterization of surface proteins with potential application in drug and vaccine development. In this study, the genome of Mycobacterium tuberculosis H37Rv was screened using Machine Learning tools that included feature-based predictors, general localizers and transmembrane topology predictors to identify proteins that are potentially secreted to the surface of M. tuberculosis, or to the extracellular milieu through different secretory pathways. The subcellular localization of a set of 8 hypothetically secreted/surface candidate proteins was experimentally assessed by cellular fractionation and immunoelectron microscopy (IEM) to determine the reliability of the computational methodology proposed here, using 4 secreted/surface proteins with experimental confirmation as positive controls and 2 cytoplasmic proteins as negative controls. Subcellular fractionation and IEM studies provided evidence that the candidate proteins Rv0403c, Rv3630, Rv1022, Rv0835, Rv0361 and Rv0178 are secreted either to the mycobacterial surface or to the extracellular milieu. Surface localization was also confirmed for the positive controls, whereas negative controls were located on the cytoplasm. Based on statistical learning methods, we obtained computational subcellular localization predictions that were experimentally assessed and allowed us to construct a computational protocol with experimental support that allowed us to identify a new set of secreted/surface proteins as potential vaccine candidates. Since the publication of the Mycobacterium tuberculosis genome in 1998, great expectations have emerged regarding speeding up the process of developing vaccines against tuberculosis. Our group has been focused on identifying molecules localized on the mycobacterial surface that could act as ligands facilitating this pathogen's entry into host cells. Immune responses exerted against these proteins might block receptor-ligand interactions, thus hampering mycobacterial invasion. Since protein fragments involved in these interactions might serve as vaccine candidates and, taking into account that a relatively small number of mycobacterial surface proteins have been experimentally identified to date due to the inherent difficulty of proteomics studies for characterizing surface proteins, in this study, we used Machine Learning-based tools available on the World Wide Web to obtain accurate predictions of surface and secreted proteins from this pathogen and found experimental support of such predictions for a group of candidate proteins selected based on novel criteria.

26 December 2008 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
DADiana I. Angel
Diana I. Angel
AMAlvaro Mongui
Alvaro Mongui
JAJavier Ardila
Javier Ardila
MVMagnolia Vanegas
Magnolia Vanegas
MPManuel Alfonso Patarroyo
Manuel Alfonso Patarroyo

1 August 2000 in Parasitology International
Verified
Journal Article
Closed access
APA Puentes
A Puentes
JCJavier Garcia Castañeda
Javier Garcia Castañeda
RVRicardo Vera
Ricardo Vera
QLQ.Ramses Lopez
Q.Ramses Lopez
MUMauricio Urquiza
Mauricio Urquiza
MPManuel Alfonso Patarroyo
Manuel Alfonso Patarroyo

16 April 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MPManuel Alfonso Patarroyo
Manuel Alfonso Patarroyo
ABAdriana Bermúdez
Adriana Bermúdez
MAMartha Patricia Alba
Martha Patricia Alba
MVMagnolia Vanegas
Magnolia Vanegas
AMArmando Moreno-Vranich
Armando Moreno-Vranich
LPLuis Antonio Poloche
Luis Antonio Poloche
Determining immune protection-inducing protein structures (IMPIPS) involves defining the stereo-electron and topochemical characteristics which are essential in MHC-p-TCR complex formation. Modified high activity binding peptides (mHABP) were thus synthesised to produce a large panel of IMPIPS measuring 26.5 ±3.5Å between the farthest atoms fitting into Pockets 1 to 9 of HLA-DRβ1* structures. They displayed a polyproline II-like (PPIIL) structure with their backbone O and N atoms orientated to establish H-bonds with specific residues from HLA-DRβ1*-peptide binding regions (PBR). Residues having specific charge and gauche+ orientation regarding p3χ1, p5χ2, and p7χ1 angles determined appropriate rotamer orientation for perfectly fitting into the TCR to induce an appropriate immune response. Immunological assays in Aotus monkeys involving IMPIPS mixtures led to promising results; taken together with the aforementioned physicochemical principles, non-interfering, long-lasting, protection-inducing, multi-epitope, multistage, minimal subunit-based chemically-synthesised peptides can be designed against diseases scourging humankind.

4 September 2003 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
MTMary H. Torres
Mary H. Torres
LSLuz M. Salazar
Luz M. Salazar
MVMagnolia Vanegas
Magnolia Vanegas
FGFanny Guzman
Fanny Guzman
RRRaul Rodriguez
Raul Rodriguez
MPManuel Alfonso Patarroyo
Manuel Alfonso Patarroyo
The merozoite surface protein‐1 represents a prime candidate for development of a malaria vaccine. Merozoite surface protein‐1 has been shown to demonstrate high‐activity peptide binding to human red blood cells. One of the high‐activity binding peptides, named 5501, located in the N‐terminus (amino acid sequence MLNISQHQCVKKQCPQNS) of the 19‐kDa molecular mass fragment of merozoite surface protein‐1, is conserved, nonimmunogenic and nonprotective. Its critical binding residues were identified and replaced with amino acids of similar mass but different charge, in order to modify their immunogenic and protective characteristics. Three analogues with positive or negative immunological results were studied by nuclear magnetic resonance to correlate their three‐dimensional structure with their biological functions. The studied peptides presented α‐helical fragments, but in different peptide regions and extensions, except for randomly structured 5501. We show that altering a few amino acids induced immunogenicity and protectivity against experimental malaria and changed the peptide three‐dimensional structure, suggesting a better fit with immune‐system molecules.